News & Events about Cti Biopharma Corp.
CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PR Newswire SEATTLE, Jan. 24, 2023 SEATTLE, Jan. 24, 2023 /PRNewswire/ -- CTI BioPharma Corp. (NASDAQ: CTIC) today announced that an...
Research and Development of Advanced Therapeutics for Ovarian Cancer Fueling Hope Research and Development of Advanced Therapeutics for Ovarian Cancer Fueling Hope PR Newswire PALM BEACH, Fla., Dec. 1, 2022 FinancialNewsMedia.com News Commentary PALM BEACH, Fla., Dec. 1, 2022 /PRNewswire/ -- The...
Ticker Report
2 months ago
CTI BioPharma Corp. (NASDAQ:CTIC Get Rating) Investment analysts at SVB Leerink cut their FY2024 EPS estimates for CTI BioPharma in a report issued on Tuesday, November 8th. SVB Leerink analyst K. Shields now anticipates that the biopharmaceutical company will earn $0.22 per share ...
CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PR Newswire SEATTLE, Sept. 21, 2022 SEATTLE, Sept. 21, 2022 /PRNewswire/ -- CTI BioPharma Corp. (NASDAQ: CTIC) today announced the grant of...
CTI BioPharma to Report Second Quarter 2022 Financial Results on August 8, 2022 CTI BioPharma to Report Second Quarter 2022 Financial Results on August 8, 2022 PR Newswire SEATTLE, Aug. 1, 2022 Company Also Announces Participation in the BTIG Biotechnology Conference and the Stifel Biotech Summer...